https://www.gavi.org/news/document-library/yellow-fever-roadmap-public-summary
Yellow fever vaccine roadmap: public summary (2024) | Gavi, the Vaccine Alliance
Gavi has been engaged in yellow fever (YF) vaccination since 2001 in support of WHO efforts to control the disease. This document is the public summary of the...
yellow fevervaccine roadmap
https://www.gavi.org/news/document-library/pneumococcal-vaccine-roadmap-public-summary
Pneumococcal vaccine roadmap: public summary (2022) | Gavi, the Vaccine Alliance
Gavi has supported routine introductions with pneumococcal vaccine since 2009. Find out more about the pneumococcal vaccine market, and Gavi’s approach to...
pneumococcal vaccineroadmap
https://www.gavi.org/news/document-library/measles-rapid-diagnostics-capacity-roadmap-public-summary-2023
Measles rapid diagnostics capacity roadmap: public summary (2023) | Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is working to make fit-for-purpose measles rapid diagnostic tests available to countries eligible for Gavi support for...
rapid diagnosticsmeaslesgavi
Sponsored https://www.cheekycrush.com/
CheekyCrush
https://www.gavi.org/news/document-library/mpox-vaccine-market-shaping-roadmap-public-summary-2025
Mpox vaccine market shaping roadmap: public summary 2025 | Gavi, the Vaccine Alliance
In 2025, the Gavi Board formally approved the establishment a global stockpile of mpox vaccines. This followed a year-long emergency response by Gavi to the...
mpox vaccineshaping roadmap
https://www.gavi.org/news-resources/knowledge-products/malaria-vaccine-market-shaping-roadmap
Malaria vaccine market shaping roadmap
malaria vaccinemarketshaping
https://www.gavi.org/news/document-library/measles-rubella-vaccine-roadmap-public-summary
Measles-rubella vaccine roadmap: public summary (2017) | Gavi, the Vaccine Alliance
Gavi’s engagement on measles dates to 2004 and rubella support began in 2011 through the measles-rubella (MR) vaccine. By the end of 2016, Gavi had supported...
rubella vaccinemeaslesroadmap
https://www.gavi.org/news-resources/knowledge-products/human-papillomavirus-hpv-vaccine-market-shaping-roadmap
Human papillomavirus (HPV) vaccine market shaping roadmap
This briefing paper provides a non-technical summary of that document. It highlights how working towards a series of key objectives and target outcomes can...
human papillomavirus hpv
https://www.gavi.org/news/document-library/human-papillomavirus-vaccine-roadmap-public-summary-2023
Human papillomavirus vaccine roadmap: public summary 2023 | Gavi, the Vaccine Alliance
Human papillomavirus (HPV) is the primary cause of cervical cancer. The roadmap is a foundational tool of Gavi’s market shaping strategy, with the purpose of...
human papillomavirusvaccine
https://www.gavi.org/news/document-library/ebola-vaccine-market-shaping-roadmap-public-summary-2025
Ebola vaccine market shaping roadmap: public summary 2025 | Gavi, the Vaccine Alliance
In 2021, Gavi helped launch the Ebola vaccine emergency stockpile of licensed vaccines to respond to outbreaks of Ebola virus disease. Subsequently in 2024,...
ebola vaccineshaping roadmap
https://www.gavi.org/news/document-library/japanese-encephalitis-vaccine-roadmap-public-summary
Japanese encephalitis vaccine roadmap: public summary (2018) | Gavi, the Vaccine Alliance
At its November 2013 Board meeting, the Vaccine Alliance opened a funding window for Japanese encephalitis (JE) catch-up campaigns in endemic countries....
vaccine roadmapjapanesepublic